Marc Cucurull
Badalona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Efficacy and safety of lorlatinib in patients with ALK- and ROS1-rearranged metastatic non-small cell lung cancer treated within the compassionate use program in Spain.
Journal: Cancer treatment and research communications
Published: November 03, 2024
Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients.
Journal: Archivos de bronconeumologia
Published: November 06, 2023
HLA-I levels correlate with survival outcomes in response to immune checkpoint inhibitors in non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 03, 2023
Addressing lung cancer screening eligibility in Spain using 2013 and 2021 US Preventive Service Task Force criteria: cross-sectional study.
Journal: ERJ open research
Published: July 10, 2023
Characterization of a cohort of metastatic lung cancer patients harboring KRAS mutations treated with immunotherapy: differences according to KRAS G12C vs. non-G12C.
Journal: Frontiers in oncology
Published: June 12, 2023
Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery.
Journal: International journal of molecular sciences
Published: June 05, 2023
Prognostic factors in patients with uterine sarcoma: the SARCUT study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 16, 2023
Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?
Journal: Exploration of targeted anti-tumor therapy
Published: April 21, 2023
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.
Journal: The Lancet. Oncology
Published: November 02, 2022
Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors.
Journal: Molecular oncology
Published: August 09, 2022
Last Updated: 09/26/2026